MEDICINE INTERACTION CHECKER

List of Medicines
SFZ DS Tablet
Add medicines to view interactions
Found 10 interactions
Life-threatening (0)
Serious (10)
Moderate (0)
Minor (0)
Beneficial (0)

SFZ DS Tablet & ATZ 50 Tablet

Concurrent use of Azathioprine and Sulfasalazine should be avoided. It may be expected to increase the risk of liver damage and bone marrow suppression (decrease in blood cell count)

+ View Interaction Details

SFZ DS Tablet & Azoran Tablet

Concurrent use of Azathioprine and Sulfasalazine should be avoided. It may be expected to increase the risk of liver damage and bone marrow suppression (decrease in blood cell count)

+ View Interaction Details

SFZ DS Tablet & Zesoris-AZ 50mg Tablet

Concurrent use of Azathioprine and Sulfasalazine should be avoided. It may be expected to increase the risk of liver damage and bone marrow suppression (decrease in blood cell count)

+ View Interaction Details

SFZ DS Tablet & Autorin 50mg Tablet

Concurrent use of Azathioprine and Sulfasalazine should be avoided. It may be expected to increase the risk of liver damage and bone marrow suppression (decrease in blood cell count)

+ View Interaction Details

SFZ DS Tablet & Vaprin Tablet

Concurrent use of Azathioprine and Sulfasalazine should be avoided. It may be expected to increase the risk of liver damage and bone marrow suppression (decrease in blood cell count)

+ View Interaction Details

SFZ DS Tablet & Azoalfa Tablet 50

Concurrent use of Azathioprine and Sulfasalazine should be avoided. It may be expected to increase the risk of liver damage and bone marrow suppression (decrease in blood cell count)

+ View Interaction Details

SFZ DS Tablet & Azanol Tablet

Concurrent use of Azathioprine and Sulfasalazine should be avoided. It may be expected to increase the risk of liver damage and bone marrow suppression (decrease in blood cell count)

+ View Interaction Details

SFZ DS Tablet & Azin Tablet

Concurrent use of Azathioprine and Sulfasalazine should be avoided. It may be expected to increase the risk of liver damage and bone marrow suppression (decrease in blood cell count)

+ View Interaction Details

SFZ DS Tablet & Imuzat 50mg Tablet

Concurrent use of Azathioprine and Sulfasalazine should be avoided. It may be expected to increase the risk of liver damage and bone marrow suppression (decrease in blood cell count)

+ View Interaction Details

SFZ DS Tablet & Azafly 50mg Tablet

Concurrent use of Azathioprine and Sulfasalazine should be avoided. It may be expected to increase the risk of liver damage and bone marrow suppression (decrease in blood cell count)

+ View Interaction Details